Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-25-000003

Director acquired 3,074 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Anderson Kenneth Carl Director 2025-01-02 Grant or award +3,074 $3.66 $11,251 119,768 D
Loading xslF345X05/wk-form4_1735938496.xml…